Yıl: 2015 Cilt: 10 Sayı: 2 Sayfa Aralığı: 120 - 129 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Beyin Kaynaklı Nörotrofik Faktör

Öz:
Beyin kaynaklı nörotrofik faktör (BDNF), nörotrofin ailesinin bir üyesi olup merkezi ve çevresel sinir sisteminde nöronların yaşamasında, büyümesinde ve fonksiyonlarında görev alır. BDNF mRNA ve protein düzeyleri serebellum, hipokampus, bulbus olfaktorius, medulla spinalis, talamus,prefrontal serebral korteks, hipotalamus, amigdala, koku sisteminin projeksiyon bölgeleri, striatum ve superior kollikulusta tespit edilmiştir. Yapılan ilk BDNF ekspresyonu çalışmalarında molekülün nöronlarla ilişkili olduğu belirlenmiş olmasına rağmen, daha sonraki çalışmalarda BDNFnin merkezi sinir sisteminde nöron harici hücrelerden, periferde vasküler endotel hücrelerinden, lenfositlerden, trombositlerden, lökositlerden, monositlerden, T ve B lenfositlerdensentezlendiği belirlenmiştir. Kalp, akciğer, böbrek, dalak ve mesane hücrelerinde de BDNF mRNA ekspresyonu rapor edilmiştir. BDNF ekspresyonu ve konsantrasyonu fizyolojik olaylarda ve patolojik durumlarda değişmektedir. BDNF, merkezi sinir sisteminde esasolarak nöronların gelişmelerine ve kendilerini yenilemelerine yardımcı olurken, önemli sinir yolaklarının yapısal olarak sağlıklı olmalarına ve görevlerini sürdürmelerine de katkıda bulunur. Sinir sisteminde nöronlarınsağkalımını desteklemesi ve nöronal fonksiyonları etkilemesinden dolayı nörodejeneratif hastalıkların tedavi edilmesinde, BDNF uygulamaları önem ve hız kazanmıştır. Bu derlemenin amacı, BDNFnin yapısı, sentezi, etki mekanizması, fonksiyonları ve tedavi amaçlı kullanımı hakkında bilgi vermektir.
Anahtar Kelime:

Konular: Biyoloji

Brain Derived Neurotrophic Factor

Öz:
Brain-derived neurotrophic factor (BDNF), is a member of neurotrophinfamily having roles in survival, growth and function of neurons in the central and peripheral nervous system. BDNF mRNA and protein levels have been identified in the cerebellum, hippocampus, bulbus olfactorius, spinal cord, thalamus, prefrontal cerebral cortex, hypothalamus, amygdala, regions of the projections of the olfactory system, striatum and superior colliculus. Although the early BDNF expression studies have demonstrated that this molecule were related with neurons, while in subsequent studies theBDNF synthesis have been determined in non-neuronal cells of central nervous system, peripheral vascular endothelial cells, lymphocytes, platelets, leukocytes, monocytes, T and B lymphocytes. Also, BDNF mRNA expression has been reported in heart, lung, kidney, spleen and urinary bladder cells. The expression and concentration of BDNF varies in physiological events and pathological situations. BDNF serves mainly to the development and refreshment of neurons in the central nervous system in addition to contributing to be structurally healthy of important nerve pathways and to the continuity of their performance. Because of the importance of BDNF to the neuronal survival and function in nervous system, applications of this neurotrophin in treatment of neurodegenerative diseases has gained importance and acceleration. The purpose of this review is to provide information about the structure, synthesis, functions and therapeutic use of BDNF.
Anahtar Kelime:

Konular: Biyoloji
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1.Lee FS., Chao MV., 2008. Neurotrophic factors. Neural Sciences, 1, 96-102.
  • 2.Honea RA., Cruchaga C., Perea RD., Saykin AJ., Burns JM., Weinberger DR., Goate AM., 2013. Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer’s Disease neurodegeneration.PLoS One, Sep 26, e76001.
  • 3.Ozawa T., Yamada K., Ichitani Y., 2014. Hippocampal BDNF treatment facilitates consolidation of spatial memory in spontaneous place recognition in rats. BehavioralBrain Research, 263, 210-216.
  • 4.Rosenblum S., Smith TN., Wang N., Chua JY., Westbroek E., Wang K., Guzman R., 2014.BDNF pre-treatment of human embryonic-derived neural stem cells improves cell survival and functional recovery after transplantation in hypoxic-ischemic stroke. Cell Transplantation[Epub ahead of print].
  • 5.Wetmore C., Cao Y., Pettersson RF., Olson L., 1991. Brain-derived neurotrophic factor: subcellular compartmentalization and interneuronal transfer as visualised with anti-peptide antibodies. Proceedingsof theNationalAcademy ofSciences, 88, 9843-9847.
  • 6.Bekinschtein P., Cammarota M., Izquierdo I., Medina JH., 2008. BDNF and Memory Formation and Storage. Neuroscientist, 14, 147-156.
  • 7.Hofer M., Pagliusu SR., Hohn A., Leibrock J., Barok YA., 1990. Regional distrubition of brain derived neurotrophic factor mRNA in the adulth mouse brain. The EMBO Journal, 9, 2459-2464.
  • 8.Rosenthal A., Goeddel DV., Nguyen T., Lewis M., Shih M., Laramee GR., Nikolics K., Winslow JW., 1990. Primary structure and biological activity of a novel human neurotrophic factor. Neuron, 4, 767-773.
  • 9.Mowla SJ., Farhadi HF., Pareek S., Atwal JK., Morris SJ., Seidah NG., MurphyRA., 2001. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. Journal ofBiologicalChemistry, 276, 12660-12666.
  • 10.Cunha C., Brambilla R., Thomas KL., 2010. A simple role for BDNF in learning and memory? Frontiers inMolecularNeuroscience, 3, 1-14.
  • 11.Tongiorgi E., Baj G., 2008. Functions and mechanisms of BDNF mRNA trafficking. Novartis FoundationSymposium, 289, 136-147.
  • 12.Dugich-Djordjevic MM., Peterson C., Isono F., Widmer HR., Denton TL., Bennett GL., HeftiF., 1995. Immunohistochemical visualization of brain-derived neurotrophic factor in the rat brain. EuropeanJournal ofNeuroscience, 7, 1831-1839.
  • 13.Phillips HS., Hains JM., LarameeGR., Rosenthal A., Winslow JW., 1990. Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. Science, 250, 290-294.
  • 14.Huntley GW., Benson DL., Jones EG., Isackson PJ., 1992. Developmental expression of brain derived neurotrophic factor mRNA by neurons of fetal and adult monkey prefrontal cortex. Brain ResearchDevelopmentalBrain Research, 70, 53-63.
  • 15.Nawa H., Carnahan J., Gail C., 1995. BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: partial disagreement with mRNA levels. European Journal of Neuroscience, 7, 1527-1535.
  • 16.Castrén E., Thoenen H., Lindholm D., 1995. Brain derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience, 64, 71-80.
  • 17.Howells DW., Porritt M., Wong JY., Batchelor PE., Kalnins R., Hughes AJ., Donan GA., 2000. Reduced BDNF mRNA expression in the Parkinson’s diseases substantia nigra. ExperimentalNeurology, 166, 127-135.
  • 18.Chen B., Dowlatshahi D., MacQueen GM., Wang JF., Young LT., 2001. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. BiologicalPsychiatry, 50, 260-265.
  • 19.Patterson SL., Grover LM., Schwartzkroin PA., Bothwell M., 1992. Neurotrophin expression in rat hippocampal slices: a stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNAs. Neuron, 9, 1081-1088.
  • 20.Bramham CR., Southard T.,Sarvey JM., Herkenhem M., Brady LS., 1996. Unilateral LTP triggers bilateral increases in hippocampal neurotrophin and trk receptor mRNA expression in behaving rats: evidence for interhemispheric communication. Journal ofComparativeNeurology, 368, 371-382.
  • 21.Neeper SA., Gomez-Pinilla F., Choi J., Cotman C., 1995. Exercise and brain neurotrophins. Nature, 373, 109.
  • 22.Scharfman HE., Mercurio TC., Goodman JH., Wilson MA., MacLusky NJ., 2003. Hippocampal excitability increases during the estrous cycle in the rat: a potential role for brain-derived neurotrophic factor. The Journal of Neuroscience, 23, 11641-11652.
  • 23.Yamamoto H., Gurney ME., 1990. Human Platelets Contain Brain-Derived Neurotrophic Factor. The Journal of Neuroscience, 11, 3469-3478.
  • 24.Kerschensteiner M., Gallmeier E., Behrens L., Leal VV., Misgeld T., Klinkert WE., Kolbeck R., Hoppe E., Oropeza-Wekerle RL., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohfeld R., 1999. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? The Journal ofExperimentalMedicine, 189, 865-870.
  • 25.Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., Wekerle H., 2000. The neuroprotective effect of inflammation: Implications for the therapy of multiple sclerosis. Journal ofNeuroimmunology, 107, 161-166.
  • 26.Gielen A., Khademi M., Muhallab S., Olsson T., Piehl F., 2003. Increased brain derived neurotrophic factor expression in white blood cells of relapsing-remitting multible sclerosis patients. Scand. The Journal ofImmunology, 57, 493-497.
  • 27.Lommatzsch M., Niewerth A., Klotz J., Schulte-Herbruggen O., Zingler C., Schuff-Werner P., 2007. Platelet and plasma BDNF in lower respiratory tract infections of the adult. RespiratoryMedicine, 101, 1493-1499.
  • 28.Scarisbrick IA., Jones EG., Isackson PJ., 1993. Coexpression of mRNAs for NGF, BDNF, and NT-3 in the cardiovascular system of the pre-and postnatal rat. The Journal ofNeuroscience, 13, 875-893.
  • 29.Yamamoto M., Sobue G., Yamamoto K., Terao S., Mitsuma T., 1996. Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues. NeurochemicalResearch, 21, 929-938.
  • 30.Lommatzsch M., Braun A., Mannsfeldt A., Botchkarev VA., Botchkareva NV., Paus R., Fischer A., Lewin GR., Renz H., 1999. Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. AmericanJournal ofPathology, 155, 1183-1193.
  • 31.Barbacid M., 1994. The Trk family of neurotrophin receptors. Journal ofNeurobiology, 25, 1386-1403.
  • 32.Chao MV., Hempstead BL., 1995. p75 and Trk: a two-receptor system. Trends in Neurosciences, 18, 321-326.
  • 33.Dechant G., Barde YA., 2002. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. NatureNeuroscience, 5, 1131-1136.
  • 34.Deinhardt K., Chao MV., 2014. Shaping neurons: Long and short range effects of mature and proBDNF signalling upon neuronal structure. Neuropharmacology, 76, 603-609.
  • 35.Lee FS., Chao MV., 2001. Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proceedings of the National Academy of Sciences, 98, 3555-3560.
  • 36.Heath D., Schmidt MB., Duman RS., 2008. Future antidepressant targets: neurotrophic factors and related signaling cascades. Drug DiscoveryToday TherapeuticStrategies, 5, 151-156.
  • 37.Woo NH., Lu B.,2009. BDNF in synaptic plasticity and memory.National institutes of Health, Bethesda, MD, USA by Elsevier Ltd.135-143.
  • 38.Jeon SJ., Rhee SY., Seo JE., Bak HR., Lee SH., Ryu JH., Cheong JH., Shin CY., Kim GH., Lee YS., Ko KH., 2011. OroxylinA increases BDNF production by activation of MAPK-CREB pathway in rat primary cortical neuronal culture. NeuroscienceResearch, 69, 214-222.
  • 39.Alderson RF., Alterman AL., Barde YA.,Lindsay RM., 1990. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron, 5, 297-306.
  • 40.Jones KR., Farinas I., Backus C., Reichardt LF., 1994. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell, 76, 989-999.
  • 41.McAllister AK., Lo DC., Katz LC., 1995.Neurothrophins regulate dendritic growth in developing visual cortex. Neuron, 15, 791-803.
  • 42.Tongiorgi E., Righi M., Cattaneo A., 1997. Activity-dependent dendritic targeting of BDNF and TrkB mRNAs in hippocampal neurons. The Journal of Neuroscience, 17, 9492-9505.
  • 43.Horch HW., Katz LC., 2002. BDNF release from single cells elicits local dendritic growth in nearby neurons. NatureNeuroscience, 5, 1177-1184.
  • 44.Leihteinen S., Pitkanan A., 2004. Brain-derived neurotophic factor signaling modifies hippocampal gene expression during epiloptogenesis in transgenic mice. European Journal of Neuroscience, 19, 3245-3254.
  • 45.Blöchl A., Sirrenberg C., 1996. Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors. Journal ofBiologicalChemistry, 271, 21100-21107.
  • 46.Tyler WJ., Pozzo-Miller LD., 2001. BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses. The Journal ofNeuroscience, 21, 4249-4258.
  • 47.Eaton MJ., Whittemore SR., 1996. Autocrine BDNF secretion enhances the survival and serotonergic differentiation of raphe neuronal precursor cells grafted into the adult rat CNS. ExperimentalNeurology, 140, 105-114.
  • 48.Suzuki S., Kiyosue K., Hazama S., Ogura A., Kashihara M., Hara T., Koshimizu H., Kojima M., 2007. Brain-Derived Neurotrophic Factor Regulates Cholesterol Metabolism for Synapse Development. The Journal of Neuroscience, 27, 6417-6427.
  • 49.Almeida LE., Roby CD., Krueger BK., 2014. Increased BDNF expression in fetal brain in the valproic acid model of autism. Molecular andCellularNeuroscience, 59C, 57-62.
  • 50.Chou D., Huang CC., Hsu KS., 2014. Brain-derived neurotrophic factor in the amygdala mediates susceptibility to fear conditioning. ExperimentalNeurology, 255, 19-29.
  • 51.Krabbe KS., Nielsen AR., Krogh-Madsen R., Plomgaard P., Rasmussen P., Erikstrup C., Fischer CP., Lindeguard B., Petersen AM., Taudorf S., Secher NH., Pilegaard H., Bruunsgaard H., Pedersen BK., 2007.Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia, 50, 431-438.
  • 52.Matthews VB., Astrom MB., Chan MH., BruceCR., Krabbe KS., Prelovsek O., Akerström T., Yfanti C., Broholm C., Mortensen OH., Penkowa M., Hojman P., Zankari A., Watt MJ., Bruunsgaard H., Pedersen BK., Febbraio MA., 2009. Brain derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP activated protein kinase. Diabetologia, 52, 1409-1418.
  • 53.Angelucci F., Aloe L., Vasquez PJ., Mathe AA., 2000. Mapping the differences in the brain of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in animal model of depression. Neuroreport,11, 1369-1373.
  • 54.Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., Nakazato M., Watanabe H., Shinoda N., Okada S., Iyo M., 2003.Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. BiologicalPsychiatry,54, 70-75.
  • 55.Sen S., Duman R., Sanacora G., 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. BiologicalPsychiatry, 64, 527-532.
  • 56.Cotman CW., Berchtold NC., 2002. Exercise: a behavioralintervention to enhance brain health and plasticity. Trends in Neurosciences, 25, 295-301.
  • 57.Mai L., Jope RS., Li X., 2002. BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. Journal ofNeurochemistry, 82, 75-83.
  • 58.Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., Aubry JM., 2002. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research, 109, 143-148.
  • 59.Phillips HS., Hains JM., Armanini M., Laramee GR., Johnson SA., Winslow JW., 1991. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron, 7, 695-702.
  • 60.Holsinger RM., Schnarr J., Henry P., Castelo VT., Fahnestock M., 2000. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcriptionpolymerase chain reaction: decreased levels in Alzheimer's disease. Brain ResearchMolecularBrain Research, 76, 347-354.
  • 61.Zuccato C., Marullo M., Conforti P., MacDonald ME., Tartari M., Cattaneo E., 2008. Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease. Brain Pathology, 2, 225-238.
  • 62.Nishio T., SunoharaN., Furukawa S., 1998. Neutrophin switching in spinal motoneurons of amyotrophic lateral sclerosis. Neuroreport, 9, 1661-1665.
  • 63.Narisawa-Saito M., Wakabayashi K., Tsuji S., Takahashi H., Nawa H., 1996. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer’s disease.Neuroreport, 7, 2925-2928.
  • 64.Laske C., Stransky E., Leyhe T., Eschweiler GW., Maetzler W., Wittorf A., Soekadar S., Richartz E., Koehler N., Bartels M., Buchkremer G., Schott K., 2007. BDNF serum and CSF concentrations in Alzheimer’s disease, normal pressure hydrocephalus and healthy controls. Journal ofPsychiatricResearch, 41, 387-394.
  • 65.Lee JG., Shin BS., You YS., Kim JE., Yoon SW., Jeon DW., BaekJH., Park SW., Kim YH., 2009. Decreased serum brain-derived neurotrophic factor levels in elderly Korean with dementia. Psychiatry Investigation, 6, 299-305.
  • 66.Forlenza OV., Diniz BS., Teixeira AL., Ojapi EB., Talib LL., Mendonça VA., Izzo G., Gattaz WF., 2010. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. The World Journal ofBiologicalPsychiatry, 11, 774-780.
  • 67.Scalzo P., Kümmer A., Bretas TL., Cardoso F., Teixeira AL., 2010. Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’s disease. Journal ofNeurology, 257, 540-545.
  • 68.Angelucci F., Oliviero A., Pilato F., Saturno E., Dileone M., Versace V., Musumeci G., Batocchi AP., Tonali PA., Di Lazzaro V., 2004. Transcranial magnetic stimulation and BDNF plasma levels in amyotrophic lateral sclerosis. Neuroreport,15, 717-720.
  • 69.Faria MC., Gonçalves GS., Rocha NP., Moraes EN., Bicalho MA., Gualberto Cintra MT., Jardim de Paula J., José Ravic de Miranda LF., Clayton de Souza Ferreira A., Teixeira AL., Gomes KB., Carvalho MD., Sousa LP., 2014. Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease. Journal ofPsychiatricResearch,53, 166-172.
  • 70.O’Bryant SE., Hobson VL., Hall JR., Barber RC., Zhang S., Johnson L., Diaz-Arrastia R., 2011. Texas Alzheimer’s research consortium. Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer’s disease cases. Dementia andGeriatricCognitiveDisorders, 31, 31-36.
  • 71.Laske C., Stransky E., Leyhe T., Eschweiler GW., Schott K., Langer H., Gawaz M., 2006. Decreased brain-derived neurotrophic factor (BDNF)-and 훽-thromboglobulin (훽-TG)-blood levels in Alzheimer’s disease. ThrombosisandHaemostasis, 96, 102-103.
  • 72.Frota ER., Rodrigues DH., Donadi EA., Brum DG., Maciel DR., Teixeira AL., 2009. Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse. NeuroscienceLetters, 460, 130-132.
  • 73.Lommatzsch M., Zingler D., Schuhbaeck K., Schloetcke K., Zingler C., Schuff-Werner P., Virchow JC., 2005. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiology ofAging, 26, 115-123.
  • 74.Sarchielli P., Greco L., Stipa A., Floridi A., Gallai V., 2002. Brain-derived neurotrophic factor in patients with multiple sclerosis. Journal ofNeuroimmunology, 132, 180-188.
  • 75.Tongiorgi E., Sartori A., Baj G., Bratina A., Di Cola F., Zorzon M., Pizzolato G., 2012. Altered serum contentof brain-derived neurotrophic factor isoforms in multiple sclerosis Journal of theNeurologicalScience, 320, 161-165.
  • 76.Kobayashi NR., Fan DP., Giehl KM., Bedard AM., Wiegand SJ., Tetzlaff W., 1997. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Ta1-tubulin mRNA expression, and promote axonal regeneration. Journal of the Neurological Science, 17, 9583-9595.
  • 77.McTigue DM., Horner PJ., Stokes BT., Gage FH., 1998. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. The Journal ofNeuroscience, 18, 5354-5365.
  • 78.Siuciak JA., Lewis DR., Wiegand SJ., Lindsay RM., 1997. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacology Biochemistryand Behavior, 56, 131-137.
  • 79.Shirayama Y., Chen AC., Nakagawa S., Russell DS., Duman RS., 2002. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. The Journal ofNeuroscience, 22, 3251-3261.
  • 80.Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry JM., Bertschy G., 2005. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. BiologicalPsychiatry, 57, 1068-1072.
  • 81.Makar TK., Trisler D., Sura KT., Sultana S., Patel N., Bever CT., 2008. Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis. Journal of theNeurologicalSciences, 270, 70-76.
  • 82.Xia Y., Wang CZ., Liu J., Anastasio NC., Johnson KM., 2010. Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways. Neuropharmacology, 58, 330-336.
  • 83.Schäbitz WR., Sommer C., Zoder W., Kiessling M., Schwaninger M., Schwab S., 2000. Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke, 9, 2212-2217.
  • 84.Lynch G., Kramar EA., Rex CS., Jia Y., Chappas D., Gall CM., Simmons DA., 2007. Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. Journal of the Neurological Sciences, 27, 4424-4434.
  • 85.Mamounas LA., Blue ME., Siuciak JA., Altar CA., 1995. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. Journal of the Neurological Sciences, 15, 7929-7939.
  • 86.Nagahara AH., Merrill DA., Coppola G., Tsukada S., Schroeder BE., Shaked GM., Wang L., Blesch A., Kim A., Conner JM., Rockenstein E., Chao MV., Koo EH., Geschwind D., Masliah E., Chiba AA., Tuszynski MH., 2009. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. NatureMedicine, 3, 331-337.
APA Kazak F, Yarim G (2015). Beyin Kaynaklı Nörotrofik Faktör. , 120 - 129.
Chicago Kazak Filiz,Yarim Gul Fatma Beyin Kaynaklı Nörotrofik Faktör. (2015): 120 - 129.
MLA Kazak Filiz,Yarim Gul Fatma Beyin Kaynaklı Nörotrofik Faktör. , 2015, ss.120 - 129.
AMA Kazak F,Yarim G Beyin Kaynaklı Nörotrofik Faktör. . 2015; 120 - 129.
Vancouver Kazak F,Yarim G Beyin Kaynaklı Nörotrofik Faktör. . 2015; 120 - 129.
IEEE Kazak F,Yarim G "Beyin Kaynaklı Nörotrofik Faktör." , ss.120 - 129, 2015.
ISNAD Kazak, Filiz - Yarim, Gul Fatma. "Beyin Kaynaklı Nörotrofik Faktör". (2015), 120-129.
APA Kazak F, Yarim G (2015). Beyin Kaynaklı Nörotrofik Faktör. Atatürk Üniversitesi Veteriner Bilimleri Dergisi, 10(2), 120 - 129.
Chicago Kazak Filiz,Yarim Gul Fatma Beyin Kaynaklı Nörotrofik Faktör. Atatürk Üniversitesi Veteriner Bilimleri Dergisi 10, no.2 (2015): 120 - 129.
MLA Kazak Filiz,Yarim Gul Fatma Beyin Kaynaklı Nörotrofik Faktör. Atatürk Üniversitesi Veteriner Bilimleri Dergisi, vol.10, no.2, 2015, ss.120 - 129.
AMA Kazak F,Yarim G Beyin Kaynaklı Nörotrofik Faktör. Atatürk Üniversitesi Veteriner Bilimleri Dergisi. 2015; 10(2): 120 - 129.
Vancouver Kazak F,Yarim G Beyin Kaynaklı Nörotrofik Faktör. Atatürk Üniversitesi Veteriner Bilimleri Dergisi. 2015; 10(2): 120 - 129.
IEEE Kazak F,Yarim G "Beyin Kaynaklı Nörotrofik Faktör." Atatürk Üniversitesi Veteriner Bilimleri Dergisi, 10, ss.120 - 129, 2015.
ISNAD Kazak, Filiz - Yarim, Gul Fatma. "Beyin Kaynaklı Nörotrofik Faktör". Atatürk Üniversitesi Veteriner Bilimleri Dergisi 10/2 (2015), 120-129.